Target intelligence / Profile preview

UBE2V1 pseudogene 6 (UBE2V1P6)

Target
UBE2V1P6
Molecular classification
Other (Pseudogene, non-functional sequence)
01

Overview

UBE2V1 pseudogene 6 (UBE2V1P6) is a non-functional genomic sequence related to the active ubiquitin-conjugating enzyme E2 variant 1 gene (UBE2V1). Unlike its protein-coding counterpart, UBE2V1P6 does not encode a functional enzyme, receptor, or protein and has no known biological activity, disease association, or utility as a drug target. Its presence is a reflection of gene duplication and evolutionary events and does not contribute to cellular function or pathology[1][3]. Most functional information available for **UBE2V1** concerns the protein-coding gene, not the pseudogene. UBE2V1 is involved in K63-linked protein ubiquitination and may play a role in disease processes, but UBE2V1P6 does not share these functions[1][3][5]. When structuring information for databases, UBE2V1P6 should be classified as a **non-functional pseudogene** with no relevant therapeutic, biomarker, drug, or mechanistic data. Queries regarding its function or role as a therapeutic target are inappropriate except in rare and specialized research contexts.

Other names
Ubiquitin conjugating enzyme E2 V1 pseudogene 6UBE2V1P6Ubiquitin conjugating enzyme E2 variant 1 pseudogene 6Ubiquitin-conjugating enzyme E2 variant 2 pseudogeneUbiquitin-conjugating enzyme E2 variant 1 pseudogene
02

Mechanism of action

None. Drug mechanisms of action do not apply to a pseudogene.

03

Biological functions

None. Pseudogenes do not have defined biological activities; UBE2V1P6 does not participate in protein ubiquitination or other cellular processes
04

Disease associations

None. UBE2V1P6 is not known to play a role in disease. Its active counterpart, UBE2V1, may be associated with disease (such as cancer or cardiomyopathy), but the pseudogene variant has no direct functional role
05

Safety considerations

None. There are no known safety concerns or therapeutic challenges specific to UBE2V1P6.
06

Interacting drugs

None. No drugs target UBE2V1P6 because pseudogenes are not functionally translated or involved in canonical pathways of drug action.
07

Biomarkers

None. UBE2V1P6 is not used as a biomarker for disease, patient selection, or therapeutic monitoring.

Beyond the preview

Go deeper on UBE2V1 pseudogene 6 (UBE2V1P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2V1 pseudogene 6 (UBE2V1P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call